SEC Form D private-offering filing
Akava Therapeutics Inc.
A new SEC Form D private-offering notice from Winnetka, IL, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Biotech developing small molecule therapeutics that inhibit protein aggregation, enzymes and cancer pathways for neurodegenerative diseases like ALS and Alzheimer's disease; lead candidate AKV9 has FDA IND clearance for an ALS Phase I trial.
Filed 2026-02-19Filed to raise $15,000,000HQ (as filed) Winnetka, ILSector Biotech ✓Stage (inferred) EarlyCall status No reported sale
Source linked the Form D on EDGAR↗Website verified akavatx.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.